Active Ingredient (In Each Tablet)
Guaifenesin 400mg
The following Structured Product Label (SPL) was submitted to the FDA by Pharbest Pharmaceuticals, Inc. for the product Guaifenesin (NDC 16103-379). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient (in each tablet), purpose, uses, warnings, stop use and ask a doctor if, if pregnant or breast-feeding,, keep out of reach of children., directions, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Guaifenesin 400mg
Expectorant
Ask doctor before use if you have
These could be signs of serious illness.
ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).
adults and children 12 years of age and over | take 1 tablet every 4 hours as needed |
children 6 to under 12 years of age | take ½ tablet every 4 hours as needed |
children under 6 years of age | consult a doctor |
magnesium stearate, maltodextrin, microcrystalline cellulose, povidone, silicon dioxide, stearic acid.
Adverse drug event call (866) 562-2756 Mon-Fri: 8 AM to 4 PM
PHARBEST
NDC 16103-379-04
Manufactured in the USA
Immediate Release
*COMPARE TO the active ingredient in MUCINEX® Tablets
PHARBINEX
Guaifenesin 400mg each
Expectorant
30 TABLETS
* Please review the disclaimer below.